A Phase I Study of ABSK211 in Participants With Advanced Solid Tumors With KRAS Alteration
A Phase I Study of ABSK211 in Participants With Advanced Solid Tumors With KRAS Alteration
Recruiting · NCT07718165 · Registry updated 2026-09-04Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase I Study of ABSK211 in Participants With Advanced Solid Tumors With KRAS Alteration | Solid Tumor (Phase I) | Recruiting | Phase 1 | 2026-09-04 | NCT07718165 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Abbisko Therapeutics Co, Ltd | 22 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Fudan University Shanghai Cancer Center | Shanghai | China | 19 |